Effects of a novel combination of orlistat and acarbose on tolerability, appetite, and glucose metabolism in persons with obesity
Summary Objective There is an unmet medical need for a safe and effective weight loss product with minimal systemic side‐effects. In this study, the effect of a novel modified‐release fixed‐dose combination of orlistat and acarbose (MR‐OA) was compared with conventional orlistat (CO) regarding toler...
Saved in:
Main Authors: | Ulf Holmbäck (Author), Anders Forslund (Author), Stefan Grudén (Author), Göran Alderborn (Author), Arvid Söderhäll (Author), Per M. Hellström (Author), Hans Lennernäs (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eating and shift work - effects on habits, metabolism and performance
by: Arne Lowden, et al.
Published: (2010) -
Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Overweight and Obese Patients
by: Alfredo Halpern, et al.
Published: (2010) -
Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
by: Aditya Maulana Perdana Putra, et al.
Published: (2021) -
Acute oxalate nephropathy associated with orlistat
by: Youshay Humayun, et al.
Published: (2016) -
Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies
by: David Dahlgren, et al.
Published: (2021)